Intellia Therapeutics(NTLA) - 2023 Q2 - Earnings Call Presentation

Return to Appendix Table of Contents | --- | --- | |-------------|----------------------------------------------------------------------------------------------------------------------------------| | | | | Increasing | • Leveraging our technology while retaining rights to key areas of focus | | shareholder | • Accelerate development of programs outside key areas of focus | | value: | • Expand our pipeline with valuable rights in future commercial success • Access external expertise to enhance our platform | ...